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This prospective clinical study aimed to evaluate effectiveness 
and tolerability of PBM in canine post-surgical wound heal-
ing.
Seven female dogs with post-neutering surgical skin wounds 
of at least 3 cm in length were selected. One-half of the wound 
was treated with a portable soft GaAlAs-laser and the other 
left untreated thus all subjects included in the study were si-
multaneously “treated” and “control”. The treated and control 
areas were evaluated and allocated a clinical score on the first 
day (D0) and at the end of laser treatment (D4). The protocol 
was twice daily, 6 minute, laser treatments for 5 days. Paired 
and un-paired t-test were used to compare scores in treated 
and control areas and between treated and control areas at D0 
and D4. Statistical significance was set at p<0.05.
Almost all treated areas had greater visible clinical improve-
ment compared to control areas. Nevertheless, statistical anal-
ysis showed that there was no significant difference between 
the total clinical score of treated areas and control areas at D0 
(P=1.0000) and no statistical significant difference between 
the two groups at D4 (P=0.2315). There was a statistically sig-
nificant decrease in exudate at D4 in treated areas compared 
to control areas (P=0.0300). There was also a statistically sig-
nificant difference between total score of the treated areas at 
D0 and at D4 (P=0.0167) but also between D0 and D4 of the 
control areas (P=0.0223). No adverse reactions were reported. 
PBM caused a visible clinical improvement of post-operative 
healing of surgical wounds, but this was not statistically sig-
nificant; however there was a statistically significant decrease 
in exudate in treated areas. It would be interesting to extend 
the study to more extensive surgical wounds in more dogs.
Abbreviation: PBM: Photobiomodulation; NIR: near-infra-
red; GaAlAs: gallium aluminum arsenide; IM: intramuscular; 
IV: intravenously; SC: subcutaneous
Introduction
Photobiomodulation (PBM), also known as “low-level laser 
therapy” or “cold laser therapy”, is a therapeutic modality 
that does not involve thermal effects, heat, sound or vibra-
tion, but rather acts through photochemical interactions that 
lead to a bio-cell stimulation [1]. Therapeutic laser use red 
and near-infrared (NIR) light with wavelengths between 300 
and 10,600 nm and various substrates, including gallium alu-
minum arsenide (GaAlAs) [2].
The basic biological mechanisms responsible for the effects of 
PBM have not yet been fully elucidated [3]. Red or NIR light 
is absorbed by cytochrome C oxidase and resulting in acti-
vation of fibroblasts, keratinocytes, and endothelial cells and 
producing a reduction of inﬂammation, pain and edema [4].
Despite the encouraging in vitro studies, clinical studies in 
human dermatology have shown conflicting results; some 
studies have reported successes with PBM in the treatment 
of skin wounds [5], keloids [6] and ulcers [7] while other 
studies [8,9] have shown PBM to be ineffective in promoting 
the healing of skin. Animal model studies on experimentally 
induced wounds or burns in rats or mice show a significant 
acceleration of healing with PBM [10,11], but other studies 
in the same species and also in pigs [12] failed to show any 
positive effects. 
There are a few clinical veterinary studies of the efficacy of 
PBM on the healing of skin wounds: in horses, with unsuc-
cessful outcomes [13,14], in cattle [15] and only few studies 
in dogs, including an experimental study on five male beagle 
dogs, with no apparent beneficial effects [16] and a clinical 
study on an individual patient with a favorable outcome [17]. 
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The main problem in human and veterinary medicine appears 
to be the absence of a standard protocol for wavelength, power, 
exposure time, type of low-intensity laser to be used for the 
different therapeutic treatments [3,5].
In view of the conflicting results highlighted by human lit-
erature, and given the scarcity of clinical data in veterinary 
medicine, the purpose of this preliminary clinical study was 
to evaluate the tolerability and the ability of PBM to reduce 
pain, swelling and inflammation and promote skin healing in 
the treatment of skin post-surgical wounds in dogs.
Materials and Methods
Healthy female dogs of different ages and breeds that had 
undergone ovariectomy for elective sterilization in a private 
veterinary clinic were included. All dogs had a linear surgical 
wound with a minimum length of 3 cm. 
All animals were client-owned dogs referred to the walk-in 
dermatology clinic at the Department of Veterinary Medicine, 
University of Milan on the day of surgery to receive the low-
laser treatment. All owners gave informed consent for PBM, 
and the recording of measurements, photographs and data. 
The study was carried out in accordance with Italian law (DL 
14 March 2014 n.26) and Europe Union legislation covering 
the use of animals for scientific purposes (“Animal Scientific 
Procedures Act” 63/2010/EU) and within the Institutional 
Ethical Guidelines.
Intradermal polydioxanone monofilament 2-0 or 3-0 (Surgic-
ryl®) or braided and coated glycolic acid polymer 2-0 or 3-0 
(Assufil ®) continuous absorbable sutures were used for skin 
closure. Immediately after surgery rifaximin topical spray (Fa-
troximin®; Fatro Spa) was applied to the surgical wound. 
All dogs were discharged from the clinic on the afternoon of 
the day of surgery, and immediately attended the Department 
for the first PBM therapy. They were then returned to their 
home environment wearing an Elizabethan collar until healing 
of the surgical wound was complete. They returned every day 
to the Department for PBM.
Post-operative analgesia was tramadol hydrochloride (Altad-
ol®; Formevet Srl) 2 mg/kg per os for 3 days and/or carprofen 
(Rimadyl®; Pfizer Italia Srl Div.Vet) 2 mg/kg per os for 3-5 days. 
On the first day of the study (D0 – the day of surgery) sig-
nalment and history were recorded and a complete physical 
examination was performed. Each patient was classified as co-
operative/non-cooperative according to whether they would 
remain for at least 10 min in lateral or dorsal recumbency on 
the examination table. Only cooperative dogs were included in 
the study. Dogs with a history of neoplastic disease were not 
included as recommended by the manufacturer of the laser 
device. 
Each dog was both a “treated” and a “control”, because only one 
half of the wound was treated with PBM with the remaining 
area acting as a control. The area of wound to be treated, was 
selected at random by an operator not involved in the study 
who did not see the dogs.
A clinical score was calculated for treated and control area (Ta-
ble 1) at D0 and on the last day of treatment (D4) in a blind 
fashion by the operator not involved in the study. The scoring 
system used was derived (with appropriate changes and addi-
tions relating to the nature of the lesions in this study) from 
the Pressure Ulcer Scale for Healing developed by the National 
Pressure Ulcer Advisory Panel as a tool to monitor changes in 
pressure ulcers over time in human patients [18], the Bates-
Jensen Wound Assessment Tool [19], and the wound bed scor-
ing for chronic wounds [20].
P a r a m -
eters
0 1 2 3 4
Skin color Pink Erythe-
matous
Dark - -
Pain None Present - - -
Granula-
tion tis-
sue
None Present - - -
E x u d at e 
(type)
N o n e /
t r a n s -
parent
Serous S e r o -
hemor-
rhagic
Hemor-
rhagic
Puru-
lent
E x u d at e 
(amount)
None Light Moder-
ate
Heavy -
Eschar None Present 
0 - 2 5 % 
surface 
area
Present, 
> 2 5 % 
surface 
area
- -
Table 1: Clinical score for objective assessment of wounds - 
derived and modified from PUSH (18), BWAT (19), and WBS 
(20) scales.
All lesions were photographed at D0 and at D4 and any side 
effects of treatment recorded. No medications other than anal-
gesia were permitted during the study period.
The laser used was the B-808-CURE LLLT (Good-Energies, 
Haifa, Israel) - a portable laser for human use, lightweight (173 
g), and equipped with rechargeable batteries. It is a diode la-
ser having a GaAlAs solid medium, with a power of 250 mW 
(micro-pulsed to ensure greater effectiveness and penetration 
with laser pulse duration of 17 µs and a work rate of 25%), a 
pulse frequency of 15 kHz, laser beam dimensions of 45 mm 
length x 10 mm widthand a wavelength of 808 nm (infrared). 
The energy density is 0.9 J/min/cm2, whereas the peak energy 
of 14.4 J/min is for the entire treated surface.
The following treatment protocol was used:
• D0: Initial application of PBM, maintaining the de-
vice as close as possible to the lesion without skin contact for 
1.5 min (to record any side effects), followed by the second ses-
sion of 6 min, after an interval of at least 30 min
• D1, D2, D3, and D4: twice daily treatment with a du-
ration of 6 min, with sessions separated by at least 3 hours.
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There was no significant difference in the total clinical score 
of treated and control areas at D0 (P=1.0000) and, despite an 
evident visual improvement in treated area compared to con-
trol area in the majority of subjects (Figure 1 and Figure 2), 
no statistically significant difference was found. No statistically 
significant difference was detected in the total clinical score be-
tween treated areas and control areas on D4 (P=0.2315). 
There was a statistically significant difference in the amount of 
exudate on D4 between treated and control areas (P= 0.030). 
There was also a statistically significant difference in the total 
score of treated area between D0 and D4 in the all subjects 
(P=0.0167), as well as between D0 and D4 (P=0.0223) of the 
control area.
All subjects included in this study were cooperative during the 
treatment. No adverse reactions or local or systemic side ef-
fects were reported during therapy.
Discussion
To the authors’ knowledge, this is the first clinical study on the 
application of PBM in post-surgical wound healing in the dog 
and one of the first clinical studies on the use of PBM in canine 
dermatology. It is, therefore, very difficult to compare our data 
with those reported in the canine literature, which is extremely 
varied.
Lucroy et al. [17] reported laser treatment of a chronic non-
surgical wound in a single dog and Olivieri et al. [21] described 
treatment of non-inflammatory alopecia in seven dogs; both 
reported a favourable outcome. Another study on the clinical 
efficacy of PBM on localized canine atopic dermatitis showed 
that the PBM was not an effective localized treatment for pedal 
pruritus [22], while a recent study on the clinical efficacy on 
canine sterile pyogranulomatous pododermatitis obtained 
positive results using the same PBM device [23]. 
In most literature studies, the effects of PBM in the healing of 
skin wounds have been studied on surgically induced lesions 
with significant tissue loss [11,13,17] where wound healing is 
by secondary intention. 
In our study we treated sutured post-surgical wounds, where 
primary healing was occurring: following the application of 
PBM, we would expect a more rapid macroscopic improve-
ment of the treated post-surgical wound area, with a reduction 
of the inflammation of the tissue surrounding the incision, a 
good reduction of skin margins and better epithelialization 
than in control sites. Although this was observed in many of 
the subjects results did not achieve statistical significance. The 
failure to reach statistical significance for this finding may have 
been due to the fact that wounds were evaluated by a clini-
cal score only and no histologic evaluation of the wounds was 
performed. A study by Ghamsari et al. (1996) [15] evaluated 
the histopathologic effects of PBM on sutured wounds at the 
level of the nipples in a group of dairy cows, and showed that 
in the treated group there was better organization of collagen 
fibres alongside better clinical appearance of healing than in 
controls.
This protocol was selected partially following the therapeutic 
indications suggested by the manufacturer of the laser device 
in their guidelines for human cases of “fresh and old surgical 
wounds and scars.”
Statistical analysis
Results were analysed using statistical software MedCalc (ver-
sion 12.7.8.0). The total population of treated and controls 
was assessed by the Kolmogorov-Smirnov test which showed 
a normal distribution of available values. A paired t-test was 
used to compare scores in treated areas at D0 and D4. The 
same evaluation was performed in the control group areas. 
The un-paired t-test was used for comparison of the scores of 
the treated areas and the control areas at D0 and D4. Statistical 
significance was set at p<0.05.
Results
Ten dogs were enrolled in the study, but 3 dogs were lost due to 
non-compliance of the owner. 
Seven dogs completed the study, all females, aged between 2 
and 9 years old, of 5 different breeds (3 crossbreed, 1 Corso 
dog, 1 Springer Spaniel, 1 Chihuahua, 1 Dachshund). Table 2 
shows the total score for each dog, for both control area and 
treated area, at D0 and D4.
Dog number days Total score
T (treated 
area)
C (control 
area)
1 D0 1 1
D4 0 0
2 D0 1 1
D4 0 1
3 D0 4 4
D4 0 1
4 D0 2 2
D4 0 0
5 D0 1 1
D4 1 0
6 D0 1 1
D4 0 1
7 D0 4 4
D4 1 2
Table 2: Total clinical scores for each dog in treated area (T) 
and control area (C), on the first (D0) and the last day of treat-
ment (D4)
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Treated area Control area
Figure 1: case n.7 at D4. Note the presence of small amount of transparent exudate on the wound and erythema in the 
control area but not in the treated area.
Control area                                                         Treated area
Figure 2: case n. 3 at D4. Note the presence of erythema and oedema in the control area but not in the treated area. 
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The bio-stimulatory effect of PBM was also confirmed histo-
logically in a group of rats, in a study investigating the role of 
laser irradiation in the healing of burns: the PBM stimulated 
the local microcirculation increasing angiogenesis, prolifera-
tion of collagen fibres, deposition of new matrix and re-epithe-
lialization of lesions undergoing treatment [10].
Not all studies on the use of PBM in skin repair have shown fa-
vourable results: Petersen et al. [13] applied laser treatment to 
surgically induced skin wounds in a group of horses, but found 
no statistically significant difference in epithelialization of the 
control areas and treated areas. Some studies in human medi-
cine have investigated the effect of PBM on ulcerative lesions 
[9] pressure ulcers, venous ulcers and other chronic wounds 
[24], but were unable to demonstrate significant difference be-
tween the subjects undergoing PBM and the control group.
However despite the lack of statistical differences between 
the clinical scores of treated and control areas at the end of 
the therapy, the results of our study in 7 dogs seem to indi-
cate a possible positive effect of PBM in the healing of surgical 
wounds. In fact, there was an evident clinical improvement of 
the treated area compared to control area in the majority of 
subjects.
The best improvements were seen in the reduction in exudate 
production, with a statistical difference between treated and 
control areas.
The reported reduction in exudate in this study is in line with 
what was observed in the study of Petersen et al. [13] in horses. 
A reduction of exudation was also demonstrated in a study 
carried out on a group of mice treated with PBM after the in-
duction of pleurisy [25].
PBM may represent a non-invasive therapy that can improve 
healing of post-surgical wounds. Successful PBM treatment 
requires good owner compliance as they must be willing to 
present their dog for at least two session of laser therapy daily 
for 5 consecutive days. In the absence of standard published 
protocols for PBM treatment in the dog, it would be useful to 
test protocols with less frequent outpatient sessions and with 
increased irradiation time.
The cooperation of patients during the laser therapy sessions 
was important to the success of treatment. Dogs in which open 
ovariectomy via ventral median celiotomy were chosen as the 
site of the wound (ventral abdomen) made patient restraint 
and handling for PBM treatment possible without the need for 
pharmacological sedation. All subjects included in this study 
were cooperative during the 6 min of treatment and this con-
firms the minimally invasive nature of the treatment. 
This study was designed as a pilot study of a clinically innova-
tive therapy on a small number of subjects following the litera-
ture on some similar studies on new treatments in dermatol-
ogy [21,23,26,27]. We chose the “case-control” study design to 
reduce the variables of clinical response and avoid confound-
ing factors such as age and breed. Having an untreated con-
trol area on each treated subject allowed us to assess the actual 
benefit of the PBM.
However, the lack of statistically significant difference between 
the treated portion and the control area, could be due to the 
fact that the laser irradiation affected not only the area directly 
treated, but also the surrounding tissues indirectly, as demon-
strated by the study of Hopkins et al. [28]. This “spill over” ef-
fect could be an important confounding factor and a possible 
major limitation of our study design.
Among the limitations encountered in the clinical evaluation 
of the effectiveness of PBM one important factor is certainly 
the absence in the literature of standard treatment protocols.
In our study, there are many reasons for the absence of statisti-
cally significant differences between the scores of treated and 
control areas at the end of the therapy: the use of an inappro-
priate wavelength, an insufficient duration of therapy, or insuf-
ficient duration of the individual irradiations performed.
Finally, a further limitation of our study is that we did not fol-
low up the patients until complete healing of the post-surgical 
wound and so have no data on time to complete healing, which 
may have been reduced by PBM.
In the light of the results obtained in this pilot study, it would 
be advisable to further investigate the clinical effects of PBM 
on post-surgical sutured wounds, in particular where the treat-
ed area and the control area are not part of the same wound. In 
addition, future studies could include further clinical evalua-
tion of low-intensity laser irradiation of lesions with extensive 
loss of substance, where healing occurs by second intention. 
This would investigate the clinical effects of bio-stimulation of 
PBM, focusing on the contraction of margins of the lesion and 
the extent of epithelialization.
Conclusion
We have demonstrated some positive effects of PBM on the 
healing of post-surgical wounds in neutered dogs. Given the 
results of this pilot study, it would be interesting to extend the 
study to confirm the validity of this type of therapy in a wider 
variety of surgical wound types in a greater number of dogs.
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